Digestive Diseases and Sciences

, Volume 49, Issue 11–12, pp 1986–1989 | Cite as

Case Report: Sirolimus Therapy in Orthotopic Liver Transplant (OLT) Recipients with Acute Renal Insufficiency

  • Marzia Montalbano
  • Guy W. NeffEmail author
  • Grabriella Slapak-Green
  • Thierry Berney
  • Douglas Meyer
orthotopic Liver Transplantation calcineurin inhibitor sirolimus 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Falkenhain ME, Cosio FG, Sedmak DD: Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine. Transplantation 62:364–370, 1996CrossRefGoogle Scholar
  2. 2.
    Grinyo JM, Gil-Vernet S, Seron D, Hueso M, Fulladosa X, Cruzado Moreso F, Fernandez A, Torras J, Riera L, Castelao AM, Alsina J: Primary immunouppression with mycophenolate mofetil and antithymocyte globin for kidney transplant recipients of a suboptimal graft. Nephrol Dial Transplant 13:2061–2064, 1998CrossRefGoogle Scholar
  3. 3.
    MacDonal AS: Management strategies for nephrotoxicity. Transplantation 69:SS31–SS36, 2000Google Scholar
  4. 4.
    McDonald AS: Management strategies for nephrotoxicity. Transplantation 69:SS31–SS36, 2000CrossRefGoogle Scholar
  5. 5.
    Mihatsch MJ, Steiner K, Abeywickrama KH, Landmann J, Thiel G: Risk factors for the development of chronic cyclosporine-nephrotoxicity. Clin Nephrol 29:165–175, 1988PubMedGoogle Scholar
  6. 6.
    Monsour HP, Wood RP, Dyer CH, Galati JS, Ozaki CF, Clark JK: Renal insufficiency and hypertension as long-term complications in liver transplantation. Semin Liver Dis 15:123–132, 1995CrossRefGoogle Scholar
  7. 7.
    Murgia M, Jordan S, Kahan B: The side effects profile of sirolimus: A phase I study in quiescent cyclosporine-prednisolone-treated renal transplant patients. Kidney Int 49:209, 1996CrossRefGoogle Scholar
  8. 8.
    Platz KT, Mueller AR, Blumhardt G, Bachmann S, Bechestein WO, Kahl P, Neuhaus P: Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506 treated patients. Transplant Int 7:S52–S57, 1994CrossRefGoogle Scholar
  9. 9.
    Porayko MK, Wiesner RH, Hay JE, Krom RAF, Dickson ER, Beaver S, Schwerman L: Bone disease in liver transplant recipients: Incidence, timing and risk factors. Transplant Proc 23:1462–1465, 1991PubMedGoogle Scholar
  10. 10.
    Rimola A, Galver JS, Schade RR, el-Lankany S, Starzl TE, van Thiel DH: Effects of renal impairment on liver transplantation. Gastroenterology 93:148–156, 1987CrossRefGoogle Scholar
  11. 11.
    Ruiz P, Kolbeck PC, Scroggs MW, Sanfilippo F: Association between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies. Transplantation 45:91–95, 1988CrossRefGoogle Scholar
  12. 12.
    Saeberg EC, et al.: Liver transplantation in the United States from 1987–1998: Update results from the UNOS Liver Transplant Registry. Clin Transplant 17–37, 1998Google Scholar
  13. 13.
    Watson CJE, Friend P, Jamieson NV, Frick TW, Alexander G, Gimson AE, Calne R: Sirolimus: A potent new immunosuppressant for liver transplantation. Transplantation 67:505–509, 1999CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2004

Authors and Affiliations

  • Marzia Montalbano
    • 1
  • Guy W. Neff
    • 1
    Email author
  • Grabriella Slapak-Green
    • 1
  • Thierry Berney
    • 1
  • Douglas Meyer
    • 1
  1. 1. Department of MedicineUniversity of MiamiMiamiUSA

Personalised recommendations